HOOKIPA Pharma Inc. Quarterly Operating Income (Loss) in USD from Q1 2018 to Q3 2024

Taxonomy & unit: us-gaap: USD
Description: The net result for the period of deducting operating expenses from operating revenues.
Summary: HOOKIPA Pharma Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q1 2018 to Q3 2024.
HOOKIPA Pharma Inc. Operating Income (Loss) for the quarter ending September 30, 2024 was -$18.6M, a 17.8% increase year-over-year.
HOOKIPA Pharma Inc. Operating Income (Loss) for the twelve months ending September 30, 2024 was -$60.9M, a 24.3% increase year-over-year.
HOOKIPA Pharma Inc. annual Operating Income (Loss) for 2023 was -$97.7M, a 33.5% decline from 2022.
HOOKIPA Pharma Inc. annual Operating Income (Loss) for 2022 was -$73.2M, a 10.4% increase from 2021.
HOOKIPA Pharma Inc. annual Operating Income (Loss) for 2021 was -$81.7M, a 53.3% decline from 2020.

Operating Income (Loss), Trailing 12 Months (USD)

Operating Income (Loss), Quarterly (USD)

Operating Income (Loss), YoY Quarterly Growth (%)

Period	TTM Value	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed
Q3 2024	-$60.9M	-$18.6M	+$4.03M	+17.8%	Jul 1, 2024	Sep 30, 2024	10-Q	2024-11-14
Q2 2024	-$64.9M	-$22.5M	-$986K	-4.59%	Apr 1, 2024	Jun 30, 2024	10-Q	2024-08-08
Q1 2024	-$63.9M	$11.1M	+$33.8M		Jan 1, 2024	Mar 31, 2024	10-Q	2024-05-09
Q4 2023	-$97.7M	-$30.9M	-$17.3M	-127%	Oct 1, 2023	Dec 31, 2023	10-K	2024-03-22
Q3 2023	-$80.4M	-$22.7M	-$1.68M	-7.99%	Jul 1, 2023	Sep 30, 2023	10-Q	2024-11-14
Q2 2023	-$78.7M	-$21.5M	-$3.05M	-16.5%	Apr 1, 2023	Jun 30, 2023	10-Q	2024-08-08
Q1 2023	-$75.7M	-$22.7M	-$2.51M	-12.5%	Jan 1, 2023	Mar 31, 2023	10-Q	2024-05-09
Q4 2022	-$73.2M	-$13.6M	+$8.46M	+38.4%	Oct 1, 2022	Dec 31, 2022	10-K	2024-03-22
Q3 2022	-$81.6M	-$21M	+$173K	+0.82%	Jul 1, 2022	Sep 30, 2022	10-Q	2023-11-09
Q2 2022	-$81.8M	-$18.4M	+$862K	+4.47%	Apr 1, 2022	Jun 30, 2022	10-Q	2023-08-10
Q1 2022	-$82.6M	-$20.1M	-$975K	-5.09%	Jan 1, 2022	Mar 31, 2022	10-Q	2023-05-11
Q4 2021	-$81.7M	-$22M	-$6.85M	-45.1%	Oct 1, 2021	Dec 31, 2021	10-K	2024-03-22
Q3 2021	-$74.8M	-$21.2M	-$4.76M	-29%	Jul 1, 2021	Sep 30, 2021	10-Q	2022-11-14
Q2 2021	-$70.1M	-$19.3M	-$10.1M	-109%	Apr 1, 2021	Jun 30, 2021	10-Q	2022-08-11
Q1 2021	-$60M	-$19.2M	-$6.71M	-53.9%	Jan 1, 2021	Mar 31, 2021	10-Q	2022-05-16
Q4 2020	-$53.3M	-$15.2M	-$1.97M	-14.9%	Oct 1, 2020	Dec 31, 2020	10-K	2023-03-15
Q3 2020	-$51.3M	-$16.4M	-$2.83M	-20.8%	Jul 1, 2020	Sep 30, 2020	10-Q	2021-11-10
Q2 2020	-$48.5M	-$9.23M	+$4.4M	+32.3%	Apr 1, 2020	Jun 30, 2020	10-Q	2021-08-12
Q1 2020	-$52.9M	-$12.5M	-$1.8M	-16.9%	Jan 1, 2020	Mar 31, 2020	10-Q	2021-05-12
Q4 2019	-$51.1M	-$13.2M	-$11M	-500%	Oct 1, 2019	Dec 31, 2019	10-K	2022-03-24
Q3 2019	-$40.1M	-$13.6M	-$8.02M	-145%	Jul 1, 2019	Sep 30, 2019	10-Q	2020-11-12
Q2 2019	-$32M	-$13.6M	-$6.65M	-95.4%	Apr 1, 2019	Jun 30, 2019	10-Q	2020-08-13
Q1 2019	-$25.4M	-$10.7M	-$4.21M	-65.2%	Jan 1, 2019	Mar 31, 2019	10-Q	2020-05-14
Q4 2018	-$21.2M	-$2.2M			Oct 1, 2018	Dec 31, 2018	10-K	2021-03-18
Q3 2018		-$5.55M			Jul 1, 2018	Sep 30, 2018	10-Q	2019-11-12
Q2 2018		-$6.98M			Apr 1, 2018	Jun 30, 2018	10-Q	2019-08-12
Q1 2018		-$6.45M			Jan 1, 2018	Mar 31, 2018	10-Q	2019-05-20

* An asterisk sign (*) next to the value indicates that the value is likely invalid.